
Brenda Raud
Postdoctoral fellow
+31 20 512 2067 b.raud@nki.nl John HaanenI joined the group of John Haanen and the Amsterdam Biotherapeutics Unit (AmBTU) in April 2019 to research T cell immunology in human cancer and to contribute to the development and clinical application of novel cancer immunotherapies based on neoantigen-specific T cells.